NDATOPICALSWAB
Approved
Jun 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PREVANTICS SWABSTICK (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2005.
Drug data last refreshed 2h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PREVANTICS SWABSTICK is a topical antiseptic swab combining chlorhexidine gluconate and isopropyl alcohol, indicated for bacterial skin antisepsis prior to invasive procedures. It is a non-systemic antimicrobial designed to reduce infection risk at injection and insertion sites.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30) suggests team consolidation and defensive positioning strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
Working on PREVANTICS SWABSTICK offers limited growth trajectory given LOE status and zero linked job openings, reflecting organizational consolidation in this mature category. Roles available are primarily defensive, focused on customer retention and pricing strategies in a commoditizing market.
Brand Manager
Worked on PREVANTICS SWABSTICK at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.